Commonwealth Equity Services, LLC Protalix Bio Therapeutics, Inc. Call Options Transaction History
Commonwealth Equity Services, LLC
- $66 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PLX
# of Institutions
48Shares Held
3.5MCall Options Held
61.1KPut Options Held
36.2K-
Jim Simons Renaissance Technologies LLC | New York, Ny956KShares$1.34 Million0.0% of portfolio
-
Gsa Capital Partners LLP London, X0435KShares$609,2980.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny374KShares$523,2590.0% of portfolio
-
Black Rock Inc. New York, NY333KShares$466,4390.0% of portfolio
-
Stratos Wealth Partners, Ltd.270KShares$378,0000.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $69.7M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...